The lncRNA BDNF-AS is an epigenetic regulator in the human amygdala in early onset alcohol use disorders.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
06 02 2019
Historique:
received: 02 08 2018
accepted: 09 12 2018
revised: 12 11 2018
entrez: 8 2 2019
pubmed: 8 2 2019
medline: 14 6 2019
Statut: epublish

Résumé

Adolescent alcohol drinking is known to contribute to the development and severity of alcohol use disorders (AUDs) later in adulthood. Recent studies have shown that long non-coding RNAs (lncRNAs) are critical for brain development and synaptic plasticity. One such lncRNA is natural occurring brain-derived neurotrophic factor antisense (BDNF-AS) that has been shown to regulate BDNF expression. The role of BDNF-AS lncRNA in the molecular mechanisms of AUD is unknown. Here, we evaluated the expression and functional role of BDNF-AS in postmortem amygdala of either early onset or late onset alcoholics (individuals who began drinking before or after 21 years of age, respectively) and age-matched control subjects. BDNF-AS expression is increased in early onset but not in late onset AUD amygdala and appears to be regulated epitranscriptomically via decreased N6-methyladenosine on BDNF-AS. Upregulation of BDNF-AS is associated with a significant decrease in BDNF expression and increased recruitment of EZH2, which deposits repressive H3K27 trimethylation (H3K27me3) at regulatory regions in the BDNF gene in the early onset AUD group. Drinking during adolescence also contributed to significant decreases in activity-regulated cytoskeleton-associated protein (ARC) expression which also appeared to be mediated by increased EZH2 deposition of repressive H3K27me3 at the ARC synaptic activity response element. These results suggest an important role for BDNF-AS in the regulation of synaptic plasticity via epigenetic reprogramming in the amygdala of AUD subjects who began drinking during adolescence.

Identifiants

pubmed: 30728347
doi: 10.1038/s41398-019-0367-z
pii: 10.1038/s41398-019-0367-z
pmc: PMC6365546
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
Cytoskeletal Proteins 0
RNA, Long Noncoding 0
BDNF protein, human 7171WSG8A2
EZH2 protein, human EC 2.1.1.43
Enhancer of Zeste Homolog 2 Protein EC 2.1.1.43

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

34

Subventions

Organisme : NIAAA NIH HHS
ID : U01 AA019971
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA024605
Pays : United States
Organisme : NIAAA NIH HHS
ID : R28 AA012725
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA022538
Pays : United States
Organisme : NIAAA NIH HHS
ID : F32 AA027410
Pays : United States
Organisme : NIAAA NIH HHS
ID : F30 AA024948
Pays : United States

Références

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):316-21
pubmed: 19116276
J Neurosci. 2002 Mar 1;22(5):1532-40
pubmed: 11880483
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7941-6
pubmed: 22547826
J Neurosci Res. 2007 Feb 15;85(3):525-35
pubmed: 17149751
Nat Rev Neurosci. 2001 Jan;2(1):24-32
pubmed: 11253356
Nucleic Acids Res. 2016 Jun 2;44(10):e91
pubmed: 26896799
Nature. 2012 Apr 29;485(7397):201-6
pubmed: 22575960
Dev Neurobiol. 2010 Apr;70(5):271-88
pubmed: 20186709
Nature. 2014 Jan 2;505(7481):117-20
pubmed: 24284625
J Neurosci. 2006 Aug 9;26(32):8320-31
pubmed: 16899727
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72
pubmed: 19571010
Lancet Public Health. 2017 May 10;2(6):e267-e276
pubmed: 28626829
Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1013-1026
pubmed: 29020412
Int Rev Neurobiol. 2014;116:275-300
pubmed: 25172479
J Epidemiol Community Health. 2007 Oct;61(10):902-7
pubmed: 17873228
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):716-21
pubmed: 18184812
Nat Protoc. 2006;1(1):179-85
pubmed: 17406230
Neurosci Biobehav Rev. 2012 Feb;36(2):873-88
pubmed: 22101113
Mol Psychiatry. 2015 Nov;20(11):1438-47
pubmed: 25450227
Sci Rep. 2018 Jul 10;8(1):10376
pubmed: 29991681
Neuroscience. 2007 May 25;146(3):1128-36
pubmed: 17395388
Biol Psychiatry. 2013 Apr 15;73(8):763-73
pubmed: 23485013
Mol Cell. 2010 Dec 22;40(6):939-53
pubmed: 21172659
Neuropsychopharmacology. 2012 Sep;37(10):2267-76
pubmed: 22617355
Psychoneuroendocrinology. 2011 Nov;36(10):1562-9
pubmed: 21596481
Lancet Psychiatry. 2014 Dec;1(7):549-58
pubmed: 26361314
Nat Biotechnol. 2012 Mar 25;30(5):453-9
pubmed: 22446693
J Subst Abuse. 2001;13(4):493-504
pubmed: 11775078
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Nature. 2012 Feb 15;482(7385):339-46
pubmed: 22337053
Addict Biol. 2017 Sep;22(5):1191-1204
pubmed: 27183824
Biol Psychiatry. 2016 Mar 15;79(6):463-73
pubmed: 26204799
Cell. 2007 Jun 29;129(7):1311-23
pubmed: 17604720
J Neurosci. 2008 Mar 5;28(10):2589-600
pubmed: 18322102
Neurobiol Dis. 2015 Oct;82:607-619
pubmed: 25814047
Alcohol Clin Exp Res. 2007 Nov;31(11):1833-8
pubmed: 17850220
Biol Psychiatry. 2016 Mar 15;79(6):427-9
pubmed: 26893193
Nat Struct Mol Biol. 2016 Feb;23(2):98-102
pubmed: 26840897
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Nat Rev Neurosci. 2016 Nov;17(11):681-691
pubmed: 27708356
Nature. 2015 Jan 15;517(7534):284-92
pubmed: 25592533
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15957-62
pubmed: 20798045
Addiction. 2004 Dec;99(12):1529-41
pubmed: 15585044
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):93-103
pubmed: 15666411
Nature. 2009 Mar 12;458(7235):223-7
pubmed: 19182780
J Biol Chem. 2015 Mar 13;290(11):6825-36
pubmed: 25623071
Psychol Addict Behav. 2013 Jun;27(2):443-54
pubmed: 22486330
Pharmacol Rev. 2012 Apr;64(2):238-58
pubmed: 22407616

Auteurs

John Peyton Bohnsack (JP)

Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA.

Tara Teppen (T)

Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Jesse Brown VA Medical Center, Chicago, IL, 60612, USA.

Evan J Kyzar (EJ)

Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA.
Jesse Brown VA Medical Center, Chicago, IL, 60612, USA.

Svetlana Dzitoyeva (S)

Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA.

Subhash C Pandey (SC)

Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, 60612, USA. scpandey@uic.edu.
Jesse Brown VA Medical Center, Chicago, IL, 60612, USA. scpandey@uic.edu.
Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, 60612, USA. scpandey@uic.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH